Literature DB >> 26385520

Inhibitory Receptor Expression on CD8+ T Cells Is Linked to Functional Responses against Trypanosoma cruzi Antigens in Chronic Chagasic Patients.

Paola Lasso1, Jose Mateus2, Paula Pavía3, Fernando Rosas4, Nubia Roa5, M Carmen Thomas6, Manuel C López6, John M González7, Concepción J Puerta3, Adriana Cuéllar8.   

Abstract

In mammals, chronic diseases resulting from infectious agents have been associated with functional T cell response deficiency, a high frequency of terminally differentiated T cells, the presence of monofunctional Ag-specific T cells, and increased expression of inhibitory receptors. Similar to other chronic diseases, the progressive loss of certain functional activities during Trypanosoma cruzi infection might result in the inability to control replication of this parasite. To examine this hypothesis, we evaluated the differentiation and cell effector function of CD8(+) T cells and characterized the expression of inhibitory receptors and the presence of the parasite in the bloodstream of chagasic patients. The results showed that patients at an advanced severe disease stage had a higher frequency of terminally differentiated CD8(+) T cells than patients at an early stage of the disease. A monofunctional CD8(+) T cell response was observed in patients at an advanced stage, whereas the coexpression of markers that perform three and four functions in response to parasite Ags was observed in patients at a less severe disease stage. The frequency of CD8(+) T cells producing granzyme B and perforin and those expressing inhibitory receptors was higher in symptomatic patients than in asymptomatic patients. Taken together, these findings suggest that during the course of Chagas disease, CD8(+) T cells undergo a gradual loss of function characterized by impaired cytokine production, the presence of advanced differentiation, and increased inhibitory receptor coexpression.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26385520     DOI: 10.4049/jimmunol.1500459

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Understanding CD8+ T Cell Immunity to Trypanosoma cruzi and How to Improve It.

Authors:  Eva V Acosta Rodríguez; Cintia L Araujo Furlan; Facundo Fiocca Vernengo; Carolina L Montes; Adriana Gruppi
Journal:  Trends Parasitol       Date:  2019-10-10

2.  A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection.

Authors:  Ana Fernández-Villegas; Elena Pérez-Antón; Inmaculada Gómez; Adriana Egui; M Carmen Thomas; Bartolomé Carrilero; Ángel Del Pozo; Maialen Ceballos; Eduardo Andrés-León; Miguel Ángel López-Ruz; Eusebio Gainza; Enrique Oquiñena; Manuel Segovia; Manuel Carlos López
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

3.  Exhausted PD-1+ TOX+ CD8+ T Cells Arise Only in Long-Term Experimental Trypanosoma cruzi Infection.

Authors:  Rosa Isela Gálvez; Thomas Jacobs
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

4.  Role of the PD-1/PD-L1 Pathway in Experimental Trypanosoma cruzi Infection and Potential Therapeutic Options.

Authors:  Yanina Arana; Rosa Isela Gálvez; Thomas Jacobs
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

5.  Expression of inhibitory receptors and polyfunctional responses of T cells are linked to the risk of congenital transmission of T. cruzi.

Authors:  Adriana Egui; Paola Lasso; María Carmen Thomas; Bartolomé Carrilero; John Mario González; Adriana Cuéllar; Manuel Segovia; Concepción Judith Puerta; Manuel Carlos López
Journal:  PLoS Negl Trop Dis       Date:  2017-06-09

Review 6.  T Cell Specificity: A Great Challenge in Chagas Disease.

Authors:  Fátima Ferragut; Gonzalo R Acevedo; Karina A Gómez
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

7.  Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses.

Authors:  María G Alvarez; Graciela L Bertocchi; Gretchen Cooley; María C Albareda; Rodolfo Viotti; Damián E Perez-Mazliah; Bruno Lococo; Melisa Castro Eiro; Susana A Laucella; Rick L Tarleton
Journal:  PLoS Negl Trop Dis       Date:  2016-04-29

8.  Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.

Authors:  Paola Lasso; Lina Beltrán; Fanny Guzmán; Fernando Rosas; M Carmen Thomas; Manuel Carlos López; John Mario González; Adriana Cuéllar; Concepción J Puerta
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

9.  T cells responding to Trypanosoma cruzi detected by membrane TNF-α and CD154 in chagasic patients.

Authors:  Juan G Ripoll; Nicolás A Giraldo; Natalia I Bolaños; Nubia Roa; Fernando Rosas; Adriana Cuéllar; Concepción J Puerta; John M González
Journal:  Immun Inflamm Dis       Date:  2017-10-01

10.  Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.

Authors:  Elena Pérez-Antón; Adriana Egui; M Carmen Thomas; Concepción J Puerta; John Mario González; Adriana Cuéllar; Manuel Segovia; Manuel Carlos López
Journal:  PLoS Negl Trop Dis       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.